CRISPR Library Focus Synbio Technologies offers CRISPR-Cas9 sgRNA libraries and related design, synthesis, and validation services, making them a strong partner for academic labs and biotech startups pursuing large-scale gene editing screens.

Antibody Discovery Edge The company provides an end-to-end antibody discovery platform with AI-guided heavy/light chain pairing, humanization, and affinity maturation, plus supporting workflows like immune repertoire sequencing and production, ideal for pharma and biotech partners seeking faster antibody development.

End-to-End DNA Solutions With reading, writing, and editing capabilities including oligo and gene synthesis, cloning, mutagenesis, variant libraries, CRISPR tools, and protein expression, Synbio can serve researchers needing streamlined, one-stop DNA solution providers.

Collaborative DNA Partners Previous partnerships with Twist Bioscience and ALSTEM demonstrate a collaboration-ready model; opportunities exist for co-development, licensing of algorithms, or joint ventures to expand library design and antibody discovery offerings.

Growth Ready Scale As a mid-sized biotech services provider with demonstrated revenue and a focused product suite, there is potential to expand client base among mid-size biotechs and academic labs, cross-sell across DNA solutions and antibody capabilities, and scale operations to capture higher project volumes.